<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Excessive intracellular accumulation of calcium has been postulated to result in ischemic neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Reduction of intracellular calcium entry should therefore be expected to reduce ischemic neuronal injury </plain></SENT>
<SENT sid="2" pm="."><plain>Two pathways through which extracellular <z:chebi fb="1" ids="39124">calcium ions</z:chebi> can enter neurons are voltage-sensitive and <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> receptor-linked <z:chebi fb="36" ids="36916">cation</z:chebi> pores </plain></SENT>
<SENT sid="3" pm="."><plain>Combined blockade of both these types of channels might be more effective in reducing intracellular calcium accumulation than the blockade of either channel alone </plain></SENT>
<SENT sid="4" pm="."><plain>We therefore evaluated the cerebroprotective effects of dizocilpine, an <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, and levemopamil, a phenylalkylamine <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi>, administered singly or in combination, in a model of forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the rat </plain></SENT>
<SENT sid="5" pm="."><plain>Four groups of rats (n = 8 each) were studied </plain></SENT>
<SENT sid="6" pm="."><plain>In the first group, dizocilpine, 5 mg/kg, was administered before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In the second group, levemopamil, 5 mg/kg, was given both preischemia and 2 h postischemia </plain></SENT>
<SENT sid="8" pm="."><plain>In the third group, both dizocilpine (5 mg/kg) and levemopamil (5 mg/kg) were given preischemia and levemopamil (5 mg/kg) was given postischemia </plain></SENT>
<SENT sid="9" pm="."><plain>The control group received saline placebo </plain></SENT>
<SENT sid="10" pm="."><plain>The rats were subjected to forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 10 min with simultaneous <z:hpo ids='HP_0002615'>hypotension</z:hpo> to 35 mm Hg </plain></SENT>
<SENT sid="11" pm="."><plain>Neuronal injury was evaluated 3 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Dizocilpine reduced postischemia neuronal injury in the ventral hippocampus (p = 0.045) </plain></SENT>
<SENT sid="13" pm="."><plain>Levemopamil and the combination of levemopamil and dizocilpine did not protect neurons from ischemic injury </plain></SENT>
<SENT sid="14" pm="."><plain>The present study does not provide support for the strategy of combined therapy with dizocilpine (administered before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) and levemopamil (administered before and after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) to protect neurons from injury produced by severe incomplete forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>